Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 187669)

Published in Antimicrob Agents Chemother on February 01, 1993

Authors

G Boivin1, A Erice, D D Crane, D L Dunn, H H Balfour

Author Affiliations

1: Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis 55455.

Articles cited by this

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53

Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med (1989) 1.78

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77

A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med (1992) 1.48

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol (1989) 1.33

Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med (1984) 1.31

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob Agents Chemother (1987) 1.27

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1991) 1.10

Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother (1987) 1.08

Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses. Virology (1991) 1.05

Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis (1990) 1.03

Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J Infect Dis (1990) 1.02

Prophylactic oral acyclovir after renal transplantation. Transplantation (1985) 0.95

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J Antimicrob Chemother (1986) 0.95

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA (1985) 0.91

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis (1992) 0.91

Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation. J Antimicrob Chemother (1985) 0.88

Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Transplant Proc (1987) 0.83

Articles by these authors

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med (1990) 12.00

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol (1996) 4.05

Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science (1998) 3.81

Acyclovir treatment of varicella in otherwise healthy children. J Pediatr (1990) 3.75

Assessing the implementation of physician-payment reform. N Engl J Med (1993) 3.71

Survival of influenza viruses on environmental surfaces. J Infect Dis (1982) 3.51

The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A (1998) 3.47

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53

Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore) (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother (1991) 2.40

Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25

An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U.S. physician payment. Med Care (1992) 2.24

Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol (1988) 2.22

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis (1997) 2.18

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med (1997) 2.06

Viability and functional activity of cryopreserved mononuclear cells. Clin Diagn Lab Immunol (2000) 2.05

Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97

Acyclovir therapy for acute herpes zoster. Lancet (1982) 1.95

Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90

Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90

Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89

Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol (1990) 1.88

Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86

Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A (2001) 1.85

Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet (1977) 1.85

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA (1987) 1.84

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83

Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83

An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med (1991) 1.80

The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79

Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis (1979) 1.77

Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol (2007) 1.77

Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75

Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75

The process of microbial translocation. Ann Surg (1990) 1.69

California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62

Practical diagnostic testing for human immunodeficiency virus. Clin Microbiol Rev (1988) 1.61

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61

Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis (1991) 1.58

Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet (1981) 1.58

Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology (1988) 1.57

Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther (1986) 1.57

Laboratory studies of acute varicella and varicella immune status. Diagn Microbiol Infect Dis (1988) 1.56

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother (1995) 1.55

Hemophiliacs with HIV antibody are actively infected. JAMA (1988) 1.55

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol (1987) 1.54

Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis (1995) 1.53

Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51

The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol (1998) 1.51

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect (1990) 1.50

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS (1999) 1.48

Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45

Acyclovir therapy in neonates. J Pediatr (1991) 1.45

Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45

Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. Surgery (2000) 1.43

2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41

Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group. J Virol Methods (1998) 1.41

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood (1986) 1.40

Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) (1986) 1.38

Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem. Am J Dis Child (1978) 1.37

Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37

Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. Transfusion (1989) 1.36

Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35

Rubella reimmunization now. Am J Dis Child (1979) 1.33

Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol (1991) 1.31

Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. N Engl J Med (1998) 1.30

Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes. J Clin Microbiol (1992) 1.29

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.28

Duodenal complications in bladder-drained pancreas transplantation. Surgery (1997) 1.27

A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother (2000) 1.27

Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. Infect Immun (1987) 1.26

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology (1989) 1.25

Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23

Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22

Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21

Concentration-controlled zidovudine therapy. Clin Pharmacol Ther (1998) 1.20

A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg (1989) 1.19